EDGAR Filing Documents for 0001144204-05-028385

Form 8-K - Current report:

SEC Accession No. 0001144204-05-028385

Filing Date

2005-09-09

Accepted

2005-09-09 06:02:24

Documents

Period of Report

2005-09-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v025453_8k.htm	8-K	56890
2		v025453_ex4-1.htm	EX-4.1	133625
3		v025453_ex4-2.htm	EX-4.2	186560
4		v025453_ex4-3.htm	EX-4.3	116302
5		v025453_ex4-4.htm	EX-4.4	101378
6		v025453_ex99-1.htm	EX-99.1	19656
7	GRAPHIC	logo.jpg	GRAPHIC	18514
	Complete submission text file	0001144204-05-028385.txt		641801

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)